Department of Public Health Sciences, School of Medicine, University of Connecticut, Farmington, 263 Farmington Ave, Farmington, CT, 06030, USA.
Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
Adm Policy Ment Health. 2020 Jul;47(4):526-530. doi: 10.1007/s10488-020-01009-2.
The Physician Payments Sunshine Act (PPSA) requires reporting of financial payments by pharmaceutical and medical device companies to teaching hospitals and individual physicians in the US. Industry payments made to psychiatrists were quantified.
Using the 2016-2017 Sunshine Act Open Payments database, general payments made to psychiatrists were descriptively analyzed. The number of psychiatrists who received payments, and median number, value (in US dollar), and nature of payments to psychiatrists were quantified. Top 10 manufacturers who paid the most to psychiatrists were also reported.
Over half of active psychiatrists (55.7%) received some form of payments from pharmaceutical manufacturers. Of these, top 2.8% of psychiatrists received 82.6% of the payments. Pharmaceutical manufacturers provided 812,877 payments worth $110,512,607.18 to 26,422 psychiatrists in the US. Compensation for services (e.g., speaker's bureaus) and consulting fees altogether constituted 71.4% of the total payment, with a median value of $1725.00 and $700, respectively. Among all psychiatrists who received payments, manufacturers that paid the most included Otsuka Pharmaceuticals, Alkermes, and Sunovion Pharmaceuticals.
The PPSA was created to foster transparent disclosure of any financial relationship between physicians and industry. Findings highlight that many active psychiatrists receive payments from pharmaceutical industry and payment forms were varied (e.g., food/beverage, educational materials, and compensation for services).
《医师阳光法案》（PPSA）要求美国制药和医疗器械公司向教学医院和个别医生报告财务支付情况。对精神科医生收到的行业支付款项进行了量化。
利用 2016-2017 年阳光法案公开支付数据库，对精神科医生的一般支付情况进行了描述性分析。量化了收到支付款项的精神科医生人数、中位数、价值（以美元计）和支付给精神科医生的款项性质。还报告了向精神科医生支付最多款项的前 10 家制造商。
超过一半的在职精神科医生（55.7%）从制药商那里获得了某种形式的报酬。其中，前 2.8%的精神科医生收到了 82.6%的报酬。制药商向美国的 26,422 名精神科医生提供了价值 110,512,607.18 美元的 812,877 笔报酬。服务补偿（如演讲者酬金）和咨询费共占总付款的 71.4%，中位数分别为 1725.00 美元和 700 美元。在所有收到付款的精神科医生中，支付最多的制造商包括大冢制药、Alkermes 和山之内制药。
PPSA 的创建是为了促进医生与行业之间任何财务关系的透明披露。研究结果表明，许多在职精神科医生从制药行业获得报酬，报酬形式多种多样（如食物/饮料、教育材料和服务补偿）。
